Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in HIV-1–Infected Women

Background. Women infected with human immunodeficiency virus (HIV) are disproportionately affected by human papillomavirus (HPV)–related anogenital disease, particularly with increased immunosuppressions. AIDS Clinical Trials Group protocol A5240 was a trial of 319 HIV-infected women in the United S...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical infectious diseases 2014-07, Vol.59 (1), p.127-135
Hauptverfasser:	Kojic, Erna Milunka, Kang, Minhee, Cespedes, Michelle S., Umbleja, Triin, Godfrey, Catherine, Allen, Reena T., Firnhaber, Cynthia, Grinsztejn, Beatriz, Palefsky, Joel M., Webster-Cyriaque, Jennifer Y., Saah, Alfred, Aberg, Judith A., Cu-Uvin, Susan
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult AIDS Antibodies Antibodies, Viral - blood Biological and medical sciences Brazil CD4 Lymphocyte Count Clinical outcomes Clinical trials Drug-Related Side Effects and Adverse Reactions Female HIV HIV 1 HIV infections HIV Infections - complications HIV-1 - isolation & purification HIV/AIDS Human immunodeficiency virus Human papillomavirus Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 Human viral diseases Humans Immune response Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Infectious diseases Lentivirus Medical sciences Middle Aged Papillomaviridae Papillomaviridae - immunology Papillomavirus Infections - prevention & control Papillomavirus vaccines Papillomavirus Vaccines - adverse effects Papillomavirus Vaccines - immunology Patient safety Registered nurses Retroviridae RNA South Africa United States Vaccination - adverse effects Vaccination - methods Vaccines Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Viral Load Womens health Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!